In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin: In vitro Bewertung von Voriconazol gegenüber klinischen Isolaten von Hefen, Schimmelpilzen und Dermatophyten im Vergleich mit Itraconazol, Ketoconazol, Amphotericin B und Griseofulvin

A Randomized Trial Comparing Fluconazole with Amphotericin B for the Treatment of Candidemia in Patients without Neutropenia

Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039 · see citing works

Therapeutic Outcome in Invasive Aspergillosis

Denning, D. W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/23.3.608 · Cited by 694 · see citing works

Oral Azole Drugs as Systemic Antifungal Therapy

Wood, A. J. J., Como, J. A., & Dismukes, W. E. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300407 · Cited by 595 · see citing works

Fungal infections in cancer patients: An international autopsy survey

Bodey, G. P., Bueltmann, B., Duguid, W. P., Gibbs, D. L., Hanak, H., Hotchi, M., Mall, G., Martino, P., Meunier, F., Milliken, S., et al. (1992) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01967060 · Cited by 546 · see citing works

NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosis

Denning, D. W., Lee, J. Y., Hostetler, J. S., Pappas, P. G., Kauffman, C. A., Dewsnup, D. H., Galgiani, J. N., Graybill, J. R., Sugar, A. M., Catanzaro, A., et al. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90023-x · Cited by 448 · see citing works

A Controlled Trial of Fluconazole or Amphotericin B to Prevent Relapse of Cryptococcal Meningitis in Patients with the Acquired Immunodeficiency Syndrome

Powderly, W. G., Saag, M. S., Cloud, G. A., Robinson, P. A., Meyer, R. D., Jacobson, J. M., Graybill, J. R., Sugar, A. M., McAuliffe, V. J., Follansbee, S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203193261203 · Cited by 351 · see citing works

Non-Candida fungal infections after bone marrow transplantation: Risk factors and outcome

Morrison, V. A., Haake, R. J., & Weisdorf, D. J. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90088-4 · Cited by 214 · see citing works

In vitro studies of activity of voriconazole (UK-109,496), a new triazole antifungal agent, against emerging and less-common mold pathogens

Radford, S. A., Johnson, E. M., & Warnock, D. W. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.4.841 · Cited by 188 · see citing works

In vitro evaluation of voriconazole against some clinically important fungi

McGinnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R., & Rinaldi, M. G. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1832 · Cited by 132 · see citing works

Antifungal Agents in the 1990s

Kauffman, C. A., & Carver, P. L. (1997) · Drugs · doi:10.2165/00003495-199753040-00001 · Cited by 128 · see citing works

In vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species

Barry, A. L., & Brown, S. D. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1948 · Cited by 125 · see citing works

Disseminated Infection with Fusarium in Recipients of Bone Marrow Transplants

Gamis, A. S., Guðnason, Þ., Giebink, G. S., & Ramsay, N. K. C. (1991) · Clinical Infectious Diseases · doi:10.1093/clinids/13.6.1077 · Cited by 100 · see citing works

The pharmacokinetics of oral itraconazole in AIDS patients

Smith, D., de Velde, V. V., Woestenborghs, R. J. H., & Gazzard, B. (1992) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1992.tb05478.x · Cited by 77 · see citing works

Fluconazole in the treatment of oropharyngeal candidosis in HIV‐positive patients

Just‐Nübling, G., Gentschew, G., Döhle, M., Böttinger, C., Helm, E.-B., & Stille, W. (1990) · Mycoses · doi:10.1111/myc.1990.33.9-10.435 · Cited by 30 · see citing works

Pharmacology and Pharmacokinetics of Traditional Systemic Antifungal Agents

Barriere, S. L. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02598.x · Cited by 24 · see citing works

The in vitro activity of fluconazole against fungi involved in dermal infections

Wildfeuer, A., & Seidl, H. (1994) · Mycoses · doi:10.1111/j.1439-0507.1994.tb00398.x · Cited by 22 · see citing works

In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.

Wildfeuer, A., Seidl, H. P., Paule, I., & Haberreiter, A. (1997) · PubMed · Cited by 19 · see citing works

Low Itraconazole Serum Concentrations Following Administration of Itraconazole Suspension to Critically Ill Allogeneic Bone Marrow Transplant Recipients

Kintzel, P. E., Rollins, C. J., Yee, W. J., & List, A. F. (1995) · Annals of Pharmacotherapy · doi:10.1177/106002809502900208 · Cited by 18 · see citing works

Efficacy and Safety of Oral Fluconazole in the Treatment of Patients with Tinea Corporis, Cruris or Pedis or Cutaneous Candidosis

Kotoğyan, A., Harmanyeri, Y., Güneş, A. T., Erboz, S., Palali, Z., Sabuncu, İ., Kot, S., Baransü, O., Karaman, A., Yazar, Ş., et al. (1996) · Clinical Drug Investigation · doi:10.2165/00044011-199612020-00001 · Cited by 9 · see citing works

ChemInform Abstract: Novel Antifungal 2‐Aryl‐1‐(1H‐1,2,4‐triazol‐1‐yl)butan‐2‐ol Derivatives with High Activity Against Aspergillus fumigatus.

DICKINSON, R. P., Bell, A., Hitchcock, C. A., Narayanaswami, S., Ray, S. J., Richardson, K., & Troke, P. F. (1996) · ChemInform · doi:10.1002/chin.199652173 · Cited by 1 · see citing works

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533 · see citing works

Human fusariosis

Dignani, M. C., & Anaissie, E. J. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00845.x · Cited by 351 · see citing works

In vitro susceptibilities of zygomycetes to conventional and new antifungals

Dannaoui, É. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg020 · Cited by 313 · see citing works

Antifungal drug resistance to azoles and polyenes

Canuto, M. M., & Rodero, F. G. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00371-7 · Cited by 310 · see citing works

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature

Espinel‐Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251 · see citing works

Population Pharmacokinetic Analysis of Voriconazole Plasma Concentration Data from Pediatric Studies

Karlsson, M. O., Lutsar, I., & Milligan, P. A. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00751-08 · Cited by 228 · see citing works

Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: A randomized, double-blind clinical trial

Weschta, M., Rimek, D., Formanek, M., Polzehl, D., Podbielski, A., & Riechelmann, H. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.03.038 · Cited by 216 · see citing works

Amphotericin B nasal lavages: Not a solution for patients with chronic rhinosinusitis

Ebbens, F. A., Scadding, G. K., Badia, L., Hellings, P. W., Jorissen, M., Mullol, J., Cardesín, A., Bachert, C., Zele, T. V., Dijkgraaf, M. G. W., et al. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.07.058 · Cited by 212 · see citing works

In Vitro Activities of 10 Antifungal Drugs against 508 Dermatophyte Strains

Fernández-Torres, B., Carrillo, A., Martin, E., del Palacio, A., Moore, M. K., Valverde, A., Serrano, M. C. L., & Guarro, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.9.2524-2528.2001 · Cited by 164 · see citing works

Novel triazole antifungal agents

Hoffman, H. L., Ernst, E. J., & Klepser, M. E. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.3.593 · Cited by 133 · see citing works

Collaborative Evaluation of Optimal Antifungal Susceptibility Testing Conditions for Dermatophytes

Fernández-Torres, B., Cabañes, F. J., Carrillo‐Muñoz, A. J., Esteban, A., Inza, I., Abarca, M. L., & Guarro, J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.3999-4003.2002 · Cited by 126 · see citing works

New Drugs and Novel Targets for Treatment of Invasive Fungal Infections in Patients with Cancer

Chiou, C. C., Groll, A. H., & Walsh, T. J. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2-120 · Cited by 123 · see citing works

Voriconazole—a new therapeutic agent with an extended spectrum of antifungal activity

Donnelly, J. P., & Pauw, B. E. D. (2004) · Clinical Microbiology and Infection · doi:10.1111/j.1470-9465.2004.00838.x · Cited by 111 · see citing works

Review of the safety and efficacy of voriconazole

Rathbun, R. C., & Hoffman, H. L. (2002) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.11.3.409 · Cited by 110 · see citing works

New antifungal agents

Gupta, A. K., & Tomas, E. T. (2003) · Dermatologic Clinics · doi:10.1016/s0733-8635(03)00024-x · Cited by 107 · see citing works

Scopulariopsis brevicaulis, a Fungal Pathogen Resistant to Broad-Spectrum Antifungal Agents

Cuenca‐Estrella, M., Gómez‐López, A., Mellado, E., Buitrago, M. J., Monzón, A., & Rodrı́guez-Tudela, J. L. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.7.2339-2341.2003 · Cited by 99 · see citing works

Inhibition of human pathogenic fungi by ethnobotanically selected plant extracts

Ficker, C., Arnason, J. T., Vindas, P. S., Álvarez, L. P., Akpagana, K., Gbéassor, M., de Souza, C., & Smith, M. L. (2003) · Mycoses · doi:10.1046/j.1439-0507.2003.00838.x · Cited by 97 · see citing works

Comparison of In Vitro Activities of 17 Antifungal Drugs against a Panel of 20 Dermatophytes by Using a Microdilution Assay

Favre, B., Hofbauer, B., Hildering, K.-S., & Ryder, N. S. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.10.4817-4819.2003 · Cited by 97 · see citing works

Novel antifungal drugs

DiDomenico, B. (1999) · Current Opinion in Microbiology · doi:10.1016/s1369-5274(99)00009-0 · Cited by 91 · see citing works

Comparison of In Vitro Activities of Voriconazole and Five Established Antifungal Agents against Different Species of Dermatophytes Using a Broth Macrodilution Method

Perea, S. H., Fothergill, A. W., Sutton, D. A., & Rinaldi, M. G. (2001) · Journal of Clinical Microbiology · doi:10.1128/jcm.39.1.385-388.2001 · Cited by 91 · see citing works

In vitro activity of antifungals against Zygomycetes

Alastruey‐Izquierdo, A., Castelli, M. V., Cuesta, I., Zaragoza, Ó., Monzón, A., Mellado, E., & Rodríguez-Tudela, J. L. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.02984.x · Cited by 83 · see citing works

Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts

Erer, B., GALIMBERTI, M., Lucarelli, G. T., Giardini, C., Polchi, P., BARONCIANI, D., Gaziev, J., Angelucci, E., & Izzi, G. C. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702231 · Cited by 82 · see citing works

The effect of topical amphotericin B on inflammatory markers in patients with chronic rhinosinusitis: A multicenter randomized controlled study

Ebbens, F. A., Georgalas, C., Luiten, S., van Drunen, C. M., Badia, L., Scadding, G. K., Hellings, P. W., Jorissen, M., Mullol, J., Cardesín, A., et al. (2009) · The Laryngoscope · doi:10.1002/lary.20064 · Cited by 78 · see citing works

Treatment of invasive fungal diseases in cancer patients—Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)

Ruhnke, M., Cornely, O. A., Schmidt‐Hieber, M., Alakel, N., Boell, B., Buchheidt, D., Christopeit, M., Hasenkamp, J., Heinz, W., Hentrich, M., et al. (2020) · Mycoses · doi:10.1111/myc.13082 · Cited by 76 · see citing works

Determination of voriconazole in aqueous humor by liquid chromatography–electrospray ionization-mass spectrometry

Zhou, L., Glickman, R. D., Chen, N., Sponsel, W. E., Graybill, J. R., & Lam, K. (2002) · Journal of Chromatography B · doi:10.1016/s1570-0232(02)00344-6 · Cited by 73 · see citing works

The Exciting Future of Antifungal Therapy

Neely, M. N., & Ghannoum, M. A. (2000) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s100960000395 · Cited by 71 · see citing works

An Overview of Antifungal Drugs and Their Use for Treatment of Deep and Superficial Mycoses in Animals

Hector, R. F. (2005) · Clinical Techniques in Small Animal Practice · doi:10.1053/j.ctsap.2005.07.005 · Cited by 70 · see citing works

Clinical characteristics and outcomes of invasive Lomentospora prolificans infections: Analysis of patients in the FungiScope ® registry

Jenks, J. D., Seidel, D., Cornely, O. A., Chen, W., van Hal, S. J., Kauffman, C. A., Miceli, M. H., Heinemann, M., Christner, M., Jover-Sáenz, A., et al. (2020) · Mycoses · doi:10.1111/myc.13067 · Cited by 63 · see citing works

The synthesis of xanthones, xanthenediones, and spirobenzofurans: Their antibacterial and antifungal activity

Omolo, J. J., Johnson, M. M., van Vuuren, S. F., & de Koning, C. B. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.088 · Cited by 59 · see citing works

Synthesis and Antifungal Activities of Novel 2-Aminotetralin Derivatives

Bin, Y., Ji, H., Cao, Y., Zhou, Y., Zhu, J., Lü, J., Li, Y., Chen, J., Zheng, C., Jiang, Y., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0701167 · Cited by 59 · see citing works

Emerging azole antifungals

Chen, A. L., & Sobel, J. D. (2005) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.10.1.21 · Cited by 60 · see citing works

Synergistic antifungal activity of statin–azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification

Cabral, M. E., Figueroa, L. I. C., & Fariña, J. I. (2013) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2012.09.006 · Cited by 54 · see citing works

Phaeohyphomycosis due to Alternaria species in transplant recipients

Boyce, R., Deziel, P. J., Otley, C. C., Wilhelm, M. P., Eid, A. J., Wengenack, N. L., & Razonable, R. R. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00482.x · Cited by 57 · see citing works

In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis

Carrillo‐Muñoz, A. J., Giusiano, G., Guarro, J., Quindós, G., Guardia, C., del Valle, O., Rodríguez, V., Estivill, D., & Cárdenes, C. D. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.04.004 · Cited by 54 · see citing works

Species Distribution and Antifungal Susceptibility Profile of Oral Candida Isolates from HIV-infected Patients in the Antiretroviral Therapy Era

Costa, C. R., Lemos, J. A., Passos, X. S., de Araújo, C. R., Cohen, A. J., Souza, L. K. H. E., & Silva, M. D. R. R. (2006) · Mycopathologia · doi:10.1007/s11046-006-0032-y · Cited by 52 · see citing works

Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy

Gerlinger, I., Fittler, A., Fonai, F., Patzkó, Á., Mayer, A., & Botz, L. (2008) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-008-0836-0 · Cited by 51 · see citing works

Imidazole Analogues of Fluoxetine, a Novel Class of Anti-CandidaAgents

Silvestri, R., Artico, M., Regina, G. L., Pasquali, A. D., Martino, G. D., D’Auria, F. D., Nencioni, L., & Palamara, A. T. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049856v · Cited by 50 · see citing works

Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy

Trinh, J. V., Steinbach, W. J., Schell, W. A., Kurtzberg, J., Giles, S. S., & Perfect, J. R. (2003) · Medical Mycology · doi:10.1080/369378031000137369 · Cited by 49 · see citing works

Two case reports: Fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient

Mattner, F., Weißbrodt, H., & Strueber, M. (2004) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540410019408 · Cited by 49 · see citing works

Voriconazole Treatment of DisseminatedPaecilomycesInfection in a Patient with Acquired Immunodeficiency Syndrome

Martin, C. A., Roberts, S., & Greenberg, R. N. (2002) · Clinical Infectious Diseases · doi:10.1086/342302 · Cited by 48 · see citing works

Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and review of the literature

Henrich, T. J., Marty, F. M., Milner, D. A., & Thorner, A. R. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00418.x · Cited by 47 · see citing works

Fungicidal activities of commonly used disinfectants and antifungal pharmaceutical spray preparations against clinical strains of Aspergillus and Candida species

Gupta, A. K., Ahmad, I., & Summerbell, R. C. (2002) · Medical Mycology · doi:10.1080/mmy.40.2.201.208 · Cited by 47 · see citing works

Antifungal Pharmacodynamics: Review of the Literature and Clinical Applications

Dodds, E. S., Drew, R. H., & Perfect, J. R. (2000) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.17.1335.34901 · Cited by 46 · see citing works

In Vitro Antifungal Susceptibilities of Uncommon Basidiomycetous Yeasts

Serena, C., Pastor, F. J., Ortoneda, M., Capilla, J., NOLARD, N., & Guarro, J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.7.2724-2726.2004 · Cited by 45 · see citing works

Comparison of NCCLS microdilution method and Etest in antifungal susceptibility testing of clinical Trichosporon asahii isolates

Arıkan, S., & Hasçelik, G. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(02)00376-0 · Cited by 44 · see citing works

Effect of Nasal Antifungal Therapy on Nasal Cell Activation Markers in Chronic Rhinosinusitis

Weschta, M., Rimek, D., Formanek, M., Podbielski, A., & Riechelmann, H. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.7.743 · Cited by 44 · see citing works

Canine and feline dermatophytosis due to Microsporum gypseum: A retrospective study of clinical data and therapy outcome with griseofulvin

Nardoni, S., Mugnaini, L., Papini, R. A., Fiaschi, M., & Mancianti, F. (2013) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2013.05.005 · Cited by 43 · see citing works

Measurement of voriconazole in serum and plasma

Langman, L. J., & Boakye‐Agyeman, F. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.07.024 · Cited by 43 · see citing works

Onychomycosis caused by Alternaria spp. in Tuscany, Italy from 1985 to 1999

Romano, C., Paccagnini, E., & Difonzo, E. M. (2001) · Mycoses · doi:10.1046/j.1439-0507.2001.00622.x · Cited by 41 · see citing works

In vitro susceptibility of clinical isolates of Zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole

Gómez‐López, A. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.6.919 · Cited by 40 · see citing works

Human Hyalohyphomycoses: A Review of Human Infections Due toAcremoniumspp.,Paecilomycesspp.,Penicilliumspp., andScopulariopsisspp.

Schinabeck, M. K., & Ghannoum, M. A. (2003) · Journal of Chemotherapy · doi:10.1179/joc.2003.15.supplement-2.5 · Cited by 38 · see citing works

Disseminated adiaspiromycosis: case report of a liver transplant patient with human immunodeficiency infection, and literature review

Pelegrín, I., Ayats, J., Xiol, X., Cuenca‐Estrella, M., Jucglá, A., Boluda, S., Sabé, N., Rafecas, A., Gudiol, F., & Cabellos, C. (2011) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2011.00611.x · Cited by 37 · see citing works

Aspergillus pragensis sp. nov. discovered during molecular reidentification of clinical isolates belonging to Aspergillus section Candidi

Hubka, V., Lysková, P., Frisvad, J. C., Peterson, S. W., Skořepová, M., & Kolařík, M. (2014) · Medical Mycology · doi:10.1093/mmy/myu022 · Cited by 37 · see citing works

Effects of disinfectants on inactivation of mold spores relevant to the food industry: a review

Visconti, V., Coton, E., Rigalma, K., & Dantigny, P. (2021) · Fungal Biology Reviews · doi:10.1016/j.fbr.2021.09.004 · Cited by 34 · see citing works

Interaction of amphotericin B lipid formulations and triazoles with human polymorphonuclear leucocytes for antifungal activity against Zygomycetes

Simitsopoulou, M., Roilides, E., Maloukou, A., Gil‐Lamaignere, C., & Walsh, T. J. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01457.x · Cited by 34 · see citing works

1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, New Imidazoles with Potent Activity againstCandida albicansand Dermatophytes. Synthesis, Structure−Activity Relationship, and Molecular Modeling Studies

Regina, G. L., D’Auria, F. D., Tafi, A., Piscitelli, F., Olla, S., Caporuscio, F., Nencioni, L., Cirilli, R., Torre, F. L., de Melo, N. R., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800009r · Cited by 33 · see citing works

In vitro interaction of micafungin with conventional and new antifungals against clinical isolates of Trichosporon, Sporobolomyces and Rhodotorula

Serena, C. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki131 · Cited by 33 · see citing works

An updated list of eumycetoma causative agents and their differences in grain formation and treatment response

van de Sande, W. W. J., & Fahal, A. H. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00034-23 · Cited by 31 · see citing works

Species of Aspergillus section Aspergillus from clinical samples in the United States

Siqueira, J. P. Z., Sutton, D. A., Gené, J., García, D., Wiederhold, N. P., & Guarro, J. (2017) · Medical Mycology · doi:10.1093/mmy/myx085 · Cited by 31 · see citing works

New and Investigational Triazole Agents for the Treatment of Invasive Fungal Infections

Sarro, A. D., Camera, E. L., & Fera, M. T. (2008) · Journal of Chemotherapy · doi:10.1179/joc.2008.20.6.661 · Cited by 31 · see citing works

Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis

Eisen, D. P., & Robson, J. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00959.x · Cited by 31 · see citing works

Antifúngicos disponibles para el tratamiento de las micosis ungueales

Carrillo‐Muñoz, A. J., Tur‐Tur, C., Hernández-Molina, J. M., Santos, P., Cárdenes, D., & Giusiano, G. (2010) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2010.01.007 · Cited by 30 · see citing works

New developments in chemotherapy for non-invasive fungal infections

Hossain, M. A., & Ghannoum, M. A. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.8.1501 · Cited by 30 · see citing works

Design, synthesis, and antifungal activities of novel triazole derivatives containing the benzyl group

Yu, S., Xu, K., Huang, L., Xu, Z. Q., Wang, Y., Bai, G.-J., Wu, Q., Wang, X., & Jiang, Y. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s74989 · Cited by 29 · see citing works

Triazole derivatives with improved in vitro antifungal activity over azole drugs

Yu, S., Chai, X., Wang, Y., Cao, Y., Zhang, J., Wu, Q., Zhang, D., Jiang, Y., Yan, T., & Sun, Q. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s58680 · Cited by 29 · see citing works

New agents for the treatment of systemic fungal infections – current status

Rex, J. H., & Arıkan, S. (2002) · Expert Opinion on Emerging Drugs · doi:10.1517/14728214.7.1.3 · Cited by 29 · see citing works

Synthesis and Anti‐Candida Potential of Certain Novel 1‐[(3‐Substituted‐3‐phenyl)propyl]‐1H‐imidazoles

Aboul-Enein, M. N., El‐Azzouny, A. A., Attia, M. I., Saleh, O. A., & Kansoh, A. L. (2011) · Archiv der Pharmazie · doi:10.1002/ardp.201000224 · Cited by 28 · see citing works

Paecilomyces variotii fungemia in a patient with multiple myeloma: case report and literature review

Salle, V., Lecuyer, E., Chouaki, T., Lescure, F.-X., Smaïl, A., Vaidie, A., Dayen, C., Schmit, J., Ducroix, J. P., & Douadi, Y. (2004) · Journal of Infection · doi:10.1016/j.jinf.2004.09.006 · Cited by 28 · see citing works

Synthesis of some Mannich base derivatives and their antimicrobial activity study

Idhayadhulla, A., Surendrakumar, R., Nasser, A. J. A., Selvin, J., & Manilal, A. (2010) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2010.12.025 · Cited by 28 · see citing works

Zygomycosis:Two Case Reports and Review of Reported Cases in the Literature in Japan

Mori, T., Egashira, M., Kawamata, N., Oshimi, K., Nakamura, K., Oguri, T., Aida, H., Hiruma, A., & 一戸, 正. (2003) · Nippon Ishinkin Gakkai Zasshi · doi:10.3314/jjmm.44.163 · Cited by 28 · see citing works

Polyphasic data support the splitting of Aspergillus candidus into two species; proposal of Aspergillus dobrogensis sp. nov.

Hubka, V., Nováková, A., Jurjević, Ž., Sklenář, F., Frisvad, J. C., Houbraken, J. A. M. P., Arendrup, M. C., Jørgensen, K. M., Siqueira, J. P. Z., Gené, J., et al. (2018) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.002583 · Cited by 27 · see citing works

New agents for treatment of systemic fungal infections

Arıkan, S., & Rex, J. H. (2000) · Emerging Drugs · doi:10.1517/14728214.5.2.135 · Cited by 26 · see citing works

Newer antifungal therapy for emerging fungal pathogens

Steinbach, W. J., & Perfect, J. R. (2003) · International Journal of Infectious Diseases · doi:10.1016/s1201-9712(03)90037-3 · Cited by 27 · see citing works

Synthesis and pharmacological properties of N‐substituted‐N′‐(4,6‐dimethylpyrimidin‐2‐yl)‐thiourea derivatives and related fused heterocyclic compounds

Saeed, S., Rashid, N., Jones, P. G., & Tahir, A. (2010) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.510 · Cited by 25 · see citing works

Synthesis and in Vitro and in Vivo Structure−Activity Relationships of Novel Antifungal Triazoles for Dermatology

Meerpoel, L., Backx, L. J. J., der Veken, L. J. E. V., Heeres, J., Corens, D., Groot, A. D., Odds, F. C., Gerven, F. V., Woestenborghs, F., Breda, A. V., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0494772 · Cited by 25 · see citing works

Actividad in vitro de anfotericina B, itraconazol y voriconazol frente a 20 especies de Aspergillus empleando el método de microdilución Sensititre®

García-Martos, P., García-Agudo, L., Jl, G. C., Ruiz-Aragón, J., Saldarreaga, A., & Marín, P. (2005) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1157/13070403 · Cited by 24 · see citing works

In vitro efficacy of a buffered chelating solution as an antimicrobial potentiator for antifungal drugs against fungal pathogens obtained from horses with mycotic keratitis

Weinstein, W. L., Moore, P. A., Sánchez, S., Dietrich, U. M., Wooley, R. E., & Ritchie, B. W. (2006) · American Journal of Veterinary Research · doi:10.2460/ajvr.67.4.562 · Cited by 24 · see citing works

Multilocus Phylogeny and Antifungal Susceptibility of Aspergillus Section Circumdati from Clinical Samples and Description of A. pseudosclerotiorum sp. nov

Siqueira, J. P. Z., Sutton, D. A., Gené, J., García, D., Wiederhold, N. P., Peterson, S. W., & Guarro, J. (2017) · Journal of Clinical Microbiology · doi:10.1128/jcm.02012-16 · Cited by 23 · see citing works

Successful treatment of resistant onychomycosis with voriconazole in a liver transplant patient

Nofal, A., Fawzy, M. M., & El‐Hawary, E. E. (2020) · Dermatologic Therapy · doi:10.1111/dth.14014 · Cited by 23 · see citing works

Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods

Alastruey‐Izquierdo, A., Cuesta, I., Ros, L., Mellado, E., & Rodríguez-Tudela, J. L. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr365 · Cited by 22 · see citing works

Trends in the treatment of dermatophytosis.

del Palacio, A., Garau, M. V., González-Escalada, A., Calvo, M. T., Kushwaha, R. K. S., & Guarro, J. (2000) · Cited by 22 · see citing works

Actividad antifúngica in vitro de voriconazol contra dermatofitos y aislamientos superficiales de Scopulariopsis brevicaulis

Carrillo‐Muñoz, A. J., Cárdenes, C. D., Carrillo-Orive, B., Rodríguez, V., del Valle, O., Casals, J. B., Ezkurra, P. A., & Quindós, G. (2005) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(05)70019-x · Cited by 22 · see citing works

Unusual dermatomycoses caused by Nannizzia nana: the geophilic origin of human infections

Gnat, S., Łagowski, D., Nowakiewicz, A., & Dyląg, M. (2020) · Infection · doi:10.1007/s15010-020-01416-5 · Cited by 21 · see citing works

Central nervous system infection due to Penicillium chrysogenum

Kantarcıoğlu, A. S., Apaydın, H., Yücel, A., de Hoog, S., Samson, R. A., Vural, M., & Özekmekçi, S. (2004) · Mycoses · doi:10.1111/j.1439-0507.2004.00974.x · Cited by 20 · see citing works

In vitro Activity of Sertaconazole against Dermatophyte Isolates with Reduced Fluconazole Susceptibility

Carrillo‐Muñoz, A. J., Fernández-Torres, B., Cárdenes, D., & Guarro, J. (2003) · Chemotherapy · doi:10.1159/000072449 · Cited by 20 · see citing works

Les champignons des genres Acremonium, Beauveria, Chrysosporium, Fusarium, Onychocola, Paecilomyces, Penicillium, Scedosporium et Scopulariopsis responsables de hyalohyphomycoses

Hocquette, A., Grondin, M., Bertout, S., & Mallié, M. (2005) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2005.06.002 · Cited by 18 · see citing works

2‐substituted 4H‐[1,3]thiazolo[3,2‐a][1,3,5]triazine‐4‐thiones: Synthesis, crystal structure, and antifungal activity

Saeed, S., Rashid, N., Jones, P. G., & Yunas, U. (2010) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.439 · Cited by 18 · see citing works

Topical 5% Natamycin With Oral Ketoconazole in Filamentous Fungal Keratitis

Rajaraman, R., Bhat, P., Vaidee, V., Maskibail, S., Raghavan, A., Sivasubramaniam, S., & Prajna, N. V. (2014) · Asia-Pacific Journal of Ophthalmology · doi:10.1097/apo.0000000000000035 · Cited by 17 · see citing works

Role of disulfide linkage in action of bis(dialkylaminethiocarbonyl)disulfides as potent double-Edged microbicidal spermicide: Design, synthesis and biology

Lal, N., Jangir, S., Bala, V., Mandalapu, D., Sarswat, A., Kumar, L., Jain, A., Kumar, L., Kushwaha, B., Pandey, A. K., et al. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.03.012 · Cited by 17 · see citing works

New options for the treatment of invasive fungal infections

Rubin, Z., & Somani, J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.02.020 · Cited by 14 · see citing works

Dermatophytosis caused by Nannizzia nana in two siblings

Bonifáz, A., Córdoba-García, B., Simancas-Llanos, T., Hernández, M. A. L., Martínez-Herrera, E. O., & Tirado‐Sánchez, A. (2019) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2018.02.003 · Cited by 14 · see citing works

A case of peritonitis caused by Rhizopus microsporus

Monecke, S., Hochauf-Stange, K., Gottschlich, B., & Ehricht, R. (2006) · Mycoses · doi:10.1111/j.1439-0507.2006.01190.x · Cited by 14 · see citing works

Comparative analysis of whole genomes and transcriptomes of Microsporum canis from invasive dermatophytosis and tinea capitis

Wang, R., Liu, W., Liu, X., Wan, Z., de Hoog, S., Li, R., & Song, Y. (2023) · Emerging Microbes & Infections · doi:10.1080/22221751.2023.2219346 · Cited by 13 · see citing works

Determination of Voriconazole Concentrations in Serum by GC‐MS

Smith, A., & Leung‐Pineda, V. (2015) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.21871 · Cited by 13 · see citing works

New imidazole derivatives of 2(3H)‐benzazolones as potential antifungal agents

Petrov, O., Gerova, M. S., Petrova, K. V., & Ivanova, Y. (2009) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.11 · Cited by 13 · see citing works

Molecular identification of phaeohyphomycosis due to Alternaria infectoria in a patient with acute myeloid leukemia—a case report

Leahy, T. R., Punnett, A., Richardson, S. E., Gharabaghi, F., & Wadhwa, A. (2009) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2009.09.019 · Cited by 12 · see citing works

Synthesis of novel Bis-1,2,4-Triazolo[3,4-b][1,3,4]Thiadiazines from natural camphoric acid as potential anti-candidal agents

Ouf, S. A., Gomha, S. M., Farag, B., Zaki, M. E. A., Ewies, M. M., Sharawy, I. A. A., Khalil, F. O., & Mahmoud, H. K. (2024) · Results in Chemistry · doi:10.1016/j.rechem.2024.101406 · Cited by 11 · see citing works

Actividad in vitro de voriconazol y otros tres antifúngicos frente a dermatofitos

Serrano, M. D. C., Chávez-Caballero, M., Valverde, A., Claro, R. M., Pemán, J., & Martín‐Mazuelos, E. (2003) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(03)72992-9 · Cited by 11 · see citing works

Systemic Infection due to Acremonium after Allogeneic Peripheral Blood Stem Cell Transplantation

Yamazaki, R., Mori, T., Aisa, Y., Nakazato, T., Mihara, A., Ikeda, Y., & Okamoto, S. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1827 · Cited by 10 · see citing works

Soft-tissue infection withAbsidia corymbiferaand kidney complications in an AIDS patient

Righi, E., Giacomazzi, C., Bassetti, M., Bisio, F., Soro, O., McDermott, J. L., Varnier, O. E., Ratto, S., & Viscoli, C. (2007) · Medical Mycology · doi:10.1080/13693780701435358 · Cited by 10 · see citing works

In vitro activity of voriconazole against yeasts, moulds and dermatophytes in comparison with fluconazole, amphotericin B and griseofulvin.

Wildfeuer, A., Seidl, H. P., Paule, I., & Haberreiter, A. (1997) · PubMed · Cited by 19 · see citing works

In Vitro Activity of the New Triazole Voriconazole (UK-109,496) against Opportunistic Filamentous and Dimorphic Fungi and Common and Emerging Yeast Pathogens

Espinel-Ingroff, A. V. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.1.198-202.1998 · Cited by 363 · see citing works

Antifungal activity of a new triazole, voriconazole (UK-109,496), compared with three other antifungal agents tested against clinical isolates of filamentous fungi

Marco, F., Pfaller, M. A., Messer, S. A., & Jones, R. N. (2008) · Medical Mycology · doi:10.1111/j.1365-280x.1998.00170.x · Cited by 8 · see citing works

In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: Review of the literature

Espinel‐Ingroff, A., Boyle, K., & Sheehan, D. J. (2001) · Mycopathologia · doi:10.1023/a:1010954803886 · Cited by 251 · see citing works

In vitro activity of voriconazole against selected fungi

Mcginnis, M. R., Pasarell, L., Sutton, D. A., Fothergill, A. W., Cooper, C. R., & Rinaldi, M. G. (2008) · Medical Mycology · doi:10.1111/j.1365-280x.1998.00153.x · Cited by 8 · see citing works